Marinus Pharma
Pharmaceutical ManufacturingPennsylvania, United States51-200 Employees
Marinus Pharmaceuticals, Inc. is a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders.
Innovative Therapeutics Marinus Pharma is focused on developing innovative therapeutics for seizure disorders, presenting an opportunity for partnership or collaboration with healthcare providers looking for cutting-edge solutions.
Favorable Financial Position With revenue in the range of $10M - 50M and recent funding of $60M, Marinus Pharma exhibits financial stability attractive for potential investors or buyers seeking profitable pharmaceutical companies for acquisition.
Competitive Landscape Analysis By comparing with similar companies like Anavex Life Sciences, CTI BioPharma, and Zynerba Pharmaceuticals, sales professionals can identify unique selling points and competitive advantages of Marinus Pharma to target specific market segments effectively.
Growth Potential Being positioned in an industry with notable players such as Intra-Cellular Therapies, Sage Therapeutics, and Ovid Therapeutics, Marinus Pharma has the opportunity to leverage market trends and expand its market share through strategic sales and marketing initiatives.
Tech-Savvy Operation Utilizing technologies like Drupal, Joomla, MySQL, and jQuery among others, Marinus Pharma demonstrates a tech-savvy approach that can be appealing to tech-oriented pharmaceutical clients seeking partners with modern digital capabilities.
Marinus Pharma uses 8 technology products and services including Drupal, Joomla, MySQL, and more. Explore Marinus Pharma's tech stack below.
Marinus Pharma Email Formats | Percentage |
FLast@marinuspharma.com | 96% |
Last@marinuspharma.com | 2% |
First.Last@marinuspharma.com | 1% |
FMiddleLast@marinuspharma.com | 1% |
Pharmaceutical ManufacturingPennsylvania, United States51-200 Employees
Marinus Pharmaceuticals, Inc. is a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders.
Marinus Pharma has raised a total of $60M of funding over 13 rounds. Their latest funding round was raised on Nov 07, 2022 in the amount of $60M.
Marinus Pharma's revenue is in the range of $10M$50M
Marinus Pharma has raised a total of $60M of funding over 13 rounds. Their latest funding round was raised on Nov 07, 2022 in the amount of $60M.
Marinus Pharma's revenue is in the range of $10M$50M